CSX

CSX Change in Working Capital

$560.00MTTM · USD

Period ending:

CSX FY Change in Working CapitalUSD
CSX FY Change in Working Capital1989-12-31: $412.00M1990-12-31: $52.00M1991-12-31: $58.00M1992-12-31: $143.00M1993-12-31: $15.00M1994-12-31: $24.00M1995-12-31: $263.00M1996-12-31: -$125.00M1997-12-31: $53.00M1998-12-31: -$90.00M1999-12-31: -$21.00M2000-12-31: -$225.00M2001-12-31: -$272.00M2002-12-31: -$53.00M2003-12-31: -$401.00M2004-12-31: $173.00M2005-12-31: -$282.00M2006-12-31: -$93.00M2007-12-31: $153.00M2008-12-31: $67.00M2009-12-31: -$4.00M2010-12-31: $210.00M2011-12-31: $119.00M2012-12-31: -$59.00M2013-12-31: $104.00M2014-12-31: -$36.00M2015-12-31: -$194.00M2016-12-31: $69.00M2017-12-31: $35.00M2018-12-31: $8.00M2019-12-31: $117.00M2020-12-31: $2.00M2021-12-31: $173.00M2022-12-31: $91.00M2023-12-31: $154.00M2024-12-31: $74.00M2025-12-31: -$244.00M$412.00M-$401.00M
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CSX change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

CSX Corporation Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-244,000,000
74,000,000
154,000,000
91,000,000
173,000,000
2,000,000
117,000,000
8,000,000
35,000,000
69,000,000
-194,000,000
-36,000,000
104,000,000
-59,000,000
119,000,000
210,000,000
-4,000,000
67,000,000
153,000,000
-93,000,000
-282,000,000
173,000,000
-401,000,000
-53,000,000
-272,000,000
-225,000,000
-21,000,000
-90,000,000
53,000,000
-125,000,000
263,000,000
24,000,000
15,000,000
143,000,000
58,000,000
52,000,000
412,000,000

Compare change in working capital

All CSX financial metrics · CSX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.